OSI SYSTEMS INC annual report, FY2012

OSI Systems, Inc. Form 10-K Summary

Reporting period: Fiscal year ended June 30, 2012. The supplied document is an annual Form 10-K, not a 2011 fourth-quarter filing; it also includes unaudited quarterly data for the quarter ended June 30, 2012.

Business Context

OSI Systems designs and manufactures specialized electronic systems and components for homeland security, healthcare, defense and aerospace markets. Its three operating divisions are Security, Healthcare, and Optoelectronics and Manufacturing.

  • Security: $391.8 million of fiscal 2012 revenue, approximately 49% of consolidated revenue.
  • Healthcare: $235.6 million of revenue, approximately 30%.
  • Optoelectronics and Manufacturing: $210.8 million of divisional revenue, including intersegment sales; third-party revenue was $165.6 million, approximately 21% of consolidated revenue.

Financial Performance and Position

MetricFiscal 2012Fiscal 2011Change
Revenue$793.0 million$656.1 million+21%
Gross profit$268.6 million$239.3 million+12%
Gross margin33.9%36.5%Down 260 bps
Operating income$65.9 million$47.8 million+38%
Operating margin8.3%7.3%Up approximately 100 bps
Net income$45.5 million$33.4 million+36%
Diluted EPS$2.24$1.71+31%
Cash flow from operations$120.6 million$40.1 million+201%
Capital expenditures$68.5 million$13.4 millionSignificant increase
Cash and cash equivalents$91.5 million$55.6 million+65%
Working capital$322.5 million$244.3 million+32%
Total debt$2.7 million$3.0 millionDown $0.3 million

SG&A increased 6% to $151.7 million, while R&D increased 9% to $49.6 million. Restructuring and other charges declined to $1.4 million from $3.4 million. The effective tax rate decreased to 26.5% from 28.5%, partly due to utilization of a previously valuation-allowanced tax loss carryforward.

Material Changes Versus the Prior Comparable Period

  • Security revenue rose 33% to $391.8 million, primarily from a large U.S. Army-related prime-contractor and hardware-systems-integration contract and higher service revenue.
  • Healthcare revenue increased 10% to $235.6 million, led by patient-monitoring sales, particularly in North America.
  • Optoelectronics and Manufacturing revenue increased 9% to $210.8 million, supported by commercial optoelectronics and contract manufacturing.
  • Gross margin contracted because of product mix, including a greater contribution from lower-margin Security hardware integration work.
  • Operating cash flow benefited substantially from approximately $100 million of customer advances associated with a large turnkey security-screening agreement.
  • Capital expenditures increased sharply, primarily for equipment and infrastructure supporting that turnkey agreement.
  • Consolidated backlog increased to approximately $1.1 billion at June 30, 2012, compared with approximately $0.3 billion at June 30, 2011. Management cautions that backlog is not necessarily indicative of future revenue.

Liquidity, Debt and Capital Allocation

The company reported $91.5 million of cash and $2.7 million of outstanding debt at June 30, 2012. It had a $425 million revolving credit facility maturing in November 2016, with no revolving borrowings outstanding and approximately $179.7 million of letters of credit outstanding. Foreign bank facilities had approximately $9.5 million of letters of credit outstanding and no debt borrowings.

The company expects operating cash flow, existing cash, credit facilities and potential capital-market access to fund foreseeable needs. Fiscal 2013 is expected to require substantial capital spending for the turnkey screening agreement. The company repurchased 67,037 shares for $6.4 million during fiscal 2012 and had 585,772 shares remaining under its repurchase authorization. It does not currently intend to pay cash dividends.

Outlook, Commentary, Risks and Unusual Items

  • Management expected the large turnkey security-screening agreement to begin operations in fiscal 2013. The related Mexican government contract has a six-year term and included a $100 million advance, for which the company must provide a guarantee until earned.
  • Management identified substantial fiscal 2013 cash-flow volatility risk because of required capital equipment and infrastructure spending before related revenues are recognized.
  • The large U.S. Army contract that materially supported fiscal 2012 revenue was not expected to generate significant revenue in fiscal 2013.
  • Fiscal 2012 included $4.3 million of start-up SG&A costs related to the turnkey screening agreement.
  • Key risks include government-budget and procurement timing, lengthy sales cycles, contract execution and acceptance delays, customer concentration, competition, product liability, medical-device regulation, foreign currency exposure, supply-chain constraints, cybersecurity, acquisitions and credit-facility covenants.
  • One Security customer represented approximately $99.2 million of fiscal 2012 consolidated revenue, or about 12.5%.
  • The company disclosed soil and groundwater contamination at its Hawthorne, California facility. No agency action or litigation was pending or threatened, and no liability was accrued because an unfavorable outcome was not considered probable and reasonably estimable.
  • Contingent acquisition-related payment obligations totaled $20.8 million at June 30, 2012, with potential maximum payments under capped arrangements of $69 million.
  • The company expects a 2.3% U.S. medical-device excise tax to begin in 2013, increasing Healthcare operating costs; the ultimate impact was described as uncertain.
  • Management and the independent auditor concluded that disclosure controls and internal control over financial reporting were effective as of June 30, 2012. The auditor issued an unqualified opinion.

Investor Verification Checklist

  • Verify the composition, timing and collectability of the $100 million customer advance and the related guarantee obligations.
  • Assess whether the approximately $1.1 billion backlog can be converted to revenue and cash flow without material cancellation, delay or margin pressure.
  • Review fiscal 2013 capital-spending requirements and the expected cash-flow profile of the Mexican turnkey screening contract.
  • Determine the effect of the U.S. Army contract roll-off on fiscal 2013 Security revenue and operating margin.
  • Examine gross-margin sustainability given the increased mix of Security hardware integration and turnkey work.
  • Monitor letters of credit, credit-facility covenants and available borrowing capacity.
  • Evaluate customer concentration, product-liability exposure, regulatory compliance and unresolved environmental matters.
  • Review contingent acquisition consideration, uncertain tax positions and potential future medical-device excise-tax costs.